For the Inventor, By the Inventor

Enter assignee name

Germantown, MD, United States of America

Precigen, Inc.

USPTO Granted Patents = 30

% Expired Patents = 3.3

CIPO Patents = 1

EPO Patents = 4

Trademarks = 1

Forward Citations = 16

Loading Chart...

Loading Chart...

60 inventors (with patents filed for the assignee):

Rutul R Shah (13 out of 15 patents)

Lily Yuin Chao (8 out of 8 patents)

James Kealey (8 out of 9 patents)

4. Xinhua Zhao (8 out of 32 patents)

5. Ramya Yarlagadda (7 out of 7 patents)

6. Mark Anton Held (6 out of 6 patents)

7. Na Trinh (6 out of 6 patents)

8. Kevin Lee Dietzel (6 out of 7 patents)

9. Cheryl G Bolinger (6 out of 6 patents)

10. Helen Sabzevari (5 out of 6 patents)

11. Simon Metenou (5 out of 5 patents)

12. Peter Emtage (4 out of 15 patents)

13. Tina Huynh (4 out of 6 patents)

14. Jeffrey Orth (4 out of 4 patents)

15. Matthias Helmut Schmalisch (4 out of 4 patents)

Core Competencies:

Electroporation

Chimeric Antigen Receptors

Human Papillomavirus

Hepatitis B

Gene Switches

Cell Tags

Methane Fermentation

Multi-Carbon Compounds

Polypeptide Compositions

Frataxin

1,4-Butanediol

2,3-Butanediol

30 patents: Sort by Forward Citations

1. 12570945 - Electroporation apparatus and method (2026-03-10),

2. 12404306 - Human papillomavirus vaccines and uses of the same (2025-09-02),

3. 12275772 - ROR-1 specific chimeric antigen receptors and uses thereof (2025-04-14),

4. 12234465 - Methods and microorganisms for the fermentation of methane to multi-carbon compounds (2025-02-25),

5. 12234261 - Hepatitis B vaccines and uses of the same (2025-02-25),

6. 12194094 - Fusion constructs and methods of using thereof (2025-01-14),

7. 12180517 - Expression of novel cell tags (2024-12-31),

8. 12091667 - Molecular switches (2024-09-17),

9. 12060585 - Expression of novel cell tags (2024-08-13),

10. 12018310 - Methods and microorganisms for making 1,4-butanediol and derivatives thereof from C1 carbons (2024-06-25),

11. 11998618 - Frataxin expression constructs (2024-06-04),

12. 11981746 - MUC16 specific chimeric antigen receptors and uses thereof (2024-05-14),

13. 11976134 - MUC16 specific chimeric antigen receptors and uses thereof (2024-05-07),

14. 11946054 - Modulating expression of polypeptides via new gene switch expression systems (2024-04-02),

15. 11939584 - Methods and microorganisms for making 2,3-butanediol and derivatives thereof from C1 carbons (2024-03-26),

Precigen, Inc. is a biotechnology company based in Germantown, Maryland, specializing in the development of innovative gene and cell therapies. The organization focuses on harnessing the power of its proprietary technologies to address unmet medical needs across various therapeutic areas, including oncology and autoimmune diseases. By leveraging advanced genetic engineering techniques, Precigen aims to create transformative treatments that enhance patient outcomes and improve quality of life, positioning itself at the forefront of the biopharmaceutical landscape.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

30 Patents

#9 in Germantown, MD

#135 in Maryland

#11,257 in US

#21,853 in the World

Germantown, MD, United States of America

Precigen, Inc.

Forward Citations = 16

60 inventors:

Rutul R Shah (13 out of 15 patents)

Lily Yuin Chao (8 out of 8 patents)

James Kealey (8 out of 9 patents)

4. Xinhua Zhao (8 out of 32 patents)

5. Ramya Yarlagadda (7 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…